SCHEMBL12286358

SCHEMBL12286358

O=C(Cl)C1=CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16922150 1.00
SCHEMBL6962688 0.81
SCHEMBL5557996 0.81
SCHEMBL7019360 0.79
SCHEMBL607166 0.79
Hydrochloric Acid SCHEMBL3721261 0.77 BLM (0.42)
SCHEMBL5264022 0.77
SCHEMBL7955999 0.77
SCHEMBL11229957 0.76
Hydrochloric Acid SCHEMBL2164758 0.76 BLM (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220275018-A1 NOVEL SPIROBICYCLIC INTERMEDIATES JANSSEN PHARMACEUTICA NV (BE) 2022-09-01 US disclosed
EP-2018364-B1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN INC (US) 2013-08-21 EP disclosed
WO-2011131749-A1 NEW 14 AND 15 MEMBERED MACROLIDES FOR THE TREATMENT OF NEUTROPHIL DOMINATED INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-10-27 WO disclosed